Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.

Acta haematologica - 1 Jan 2007

Wang Y Lynn, Lee Joong W, Kui Jonathan S, Chadburn Amy, Cross Nicholas C P, Knowles Daniel M, Coleman Morton

Abstract excerpt

BACKGROUND/AIMS: The JAK2(V617F) mutation, which has been found in patients with myeloproliferative disorders (MPD), has not yet been evaluated in lymphoproliferative disorders by any adequately sensitive techniques. METHODS: We investigated whether low levels of JAK2(V617F) are present in lympho...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Janus Kinase 2
Share to Leukemia, Lymphocytic, Chronic, B-Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, B-Cell

Share to Lymphoma, B-Cell, Marginal Zone

Share to Lymphoma, Large B-Cell, Diffuse

Share to Lymphoma, T-Cell

Share to Neoplasms, Second Primary

Source

Identifiers

PMID: 18032883
DOI: 10.1159/000111532

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18032883-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.PMID 18032883Read ↗

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.Semantic proximity Read ↗

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.Semantic proximity Read ↗

Detection Mutations of JAK2 exon 12 in Patients with JAK2 (V617F)-negative Myeloproliferative Disorders.Semantic proximity Read ↗

Laboratory detection of JAK2V617F in human myeloproliferative neoplasms.Semantic proximity Read ↗

Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology.Semantic proximity Read ↗

Relevance of JAK2V617F positivity to hematological diseases--survey of samples from a clinical genetics laboratory.Semantic proximity Read ↗

The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis.Semantic proximity Read ↗

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersSemantic proximity Read ↗

Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms.Semantic proximity Read ↗

Acquired mutation of the tyrosine kinase JAK2V617F in Egyptian patients with myeloid disorders.Semantic proximity Read ↗

Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.